HCA · HCA Healthcare, Inc.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
| Program Announced | Authorized | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-01-01 | $10,000,000,000 | $7,210,000,000 | 2026-06-30 | — | 10-Q , filed 2026-07-28 |
Cash spent on buybacks by quarter
Cash deployed each quarter, with the average price paid where the company reported it. Δ marks quarters derived from the company's cumulative year-to-date disclosures.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2026-03-31 YTD | $1,571,000,000 | 10-Q, filed 2026-04-29 |
| 2025-12-31 | $10,067,000,000 | 10-K, filed 2026-02-10 |
| 2024-12-31 | $6,042,000,000 | 10-K, filed 2026-02-10 |
| 2023-12-31 | $3,811,000,000 | 10-K, filed 2026-02-10 |
| 2022-12-31 | $7,000,000,000 | 10-K, filed 2025-02-14 |
| 2021-12-31 | $8,215,000,000 | 10-K, filed 2024-02-16 |
| 2020-12-31 | $441,000,000 | 8-K, filed 2023-05-26 |
| 2019-12-31 | $1,031,000,000 | 10-K, filed 2022-02-18 |
| 2018-12-31 | $1,530,000,000 | 10-K, filed 2021-02-19 |
| 2017-12-31 | $2,051,000,000 | 10-K, filed 2020-02-20 |
| 2016-12-31 | $2,751,000,000 | 10-K, filed 2019-02-21 |
| 2015-12-31 | $2,397,000,000 | 10-K, filed 2018-02-23 |
| 2014-12-31 | $1,750,000,000 | 10-K, filed 2017-02-22 |
| 2013-12-31 | $500,000,000 | 10-K, filed 2016-02-26 |
| 2011-12-31 | $1,503,000,000 | 10-K, filed 2014-02-26 |